2018 annual financial data
Heron Therapeutics 2018 Operating margin
Direct answer
Operating margin was -237.42%.
Operating income was -183,937,000 USD and net income was -178,840,000 USD.
Operating cash flow was -191,805,000 USD.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 77,474,000 USD
- Operating income
- -183,937,000 USD
- Net income
- -178,840,000 USD
- Operating cash flow
- -191,805,000 USD